Dongbang Transport & Logistics KRX:004140KOSPI
동방 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked6since Sep 11
In Q2 2026, Dongbang Transport & Logistics reported revenue of ₩242bn, up 9.8% year on year, and operating profit of ₩5.3bn. Dongbang Transport & Logistics (동방) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Oct 19 with 1 article. It was most often mentioned alongside Hyundai Livart Furniture and Hanssem.
Filing signals Asset deal Screener
Dongbang Transport & Logistics quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩242bn | +9.8% | ₩5.3bn margin 2.2% | ₩1.4bn |
| Q1 2026 | ₩241bn | +17.7% | ₩6.5bn margin 2.7% | ₩2.1bn |
| Q4 2025 derived | ₩252bn | +12.0% | ₩4.3bn margin 1.7% | −₩666m |
| Q3 2025 | ₩238bn | +10.2% | ₩11.8bn margin 5.0% | ₩4.1bn |
| Q2 2025 | ₩221bn | +0.2% | ₩7.1bn margin 3.2% | ₩7.7bn |
| Q1 2025 | ₩205bn | -2.6% | ₩8.7bn margin 4.2% | ₩6.2bn |
| Q4 2024 derived | ₩225bn | +14.5% | ₩9.1bn margin 4.1% | −₩2.5bn |
| Q3 2024 | ₩216bn | +15.6% | ₩12.1bn margin 5.6% | ₩1.4bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Dongbang Transport & Logistics top stories 2 weeks, by number of outlets
- 1
- 2
Latest Dongbang Transport & Logistics news Korean headlines
-
한샘·현대리바트·동방 ‘담합 또 담합’…7년간 3건 이상 적발 사업자 65곳
4 more on this story · 4 outlets
- 7년간 담합 3건 이상 적발된 사업자 65곳…한샘 20건 '최다'연합뉴스TV · Oct 19 09:48
- 담합 사건 3건 이상 포함된 사업자 65곳…한샘 20건 최다뉴시스경제 · Oct 19 10:10
- 7년새 담합 사건 3건 이상 연루 65곳…한샘 20건 최다알파경제 · Oct 19 10:15
- 담합 사건 3번 이상 이름 올린 사업자 65곳… 한샘 20건 최다한국일보 · Oct 19 10:44
-
바스젠바이오·동방에프티엘, 중기부 AI 신약 개발 국책과제 선정
1 more on this story · 1 outlets
- 바스젠바이오-동방에프티엘, 중기부 AI 신약개발 국책과제 선정…이중표적 항암제 개발바이오타임즈 · Sep 17 18:06